From the ELISA assay of severe COVID‐19 patients’ plasma, we found that the concentration of soluble endothelial protein C receptor (sEPCR) was increased as the severity of COVID‐19 increased (Figure2a). The gene discussed is PROCR; the disease is COVID-19.